Conclusion Over the past years, GLP-1 antagonists have become a game-changer in weight management, offering a powerful tool for those struggling with obesity or Type 2 diabetes
Also, unlike therapies that are used to treat blood pressure or cholesterol, the perception that these are not chronic disease therapies may also be contributing
Drucker DJ (2024): Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Look for bars with: 15-20g protein, under 5g added sugar, under 200 calories, at least 3g fiber, and minimal artificial ingredients
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men
Recent work suggests that ghrelin also controls glucose metabolism